Merck & Co., Inc.MRK

時価総額

$2517.6億

PER

研究開発型バイオ医薬品・ワクチン・動物用製品の世界最大手。がん免疫療法やワクチン、デジタル獣医保健ソリューションを展開。2024年7月に眼科バイオ企業を約12億ドルで買収。米国・欧州・中国や新興市場を中心に展開。

	2010年 12月31日	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	10,900	13,531	13,451	15,621	7,441	8,524	6,515	6,092	7,965	9,676	8,062	8,096	12,694	6,841	13,242
Short-term investments	1,301	1,441	2,690	1,865	8,278	4,903	7,826	2,406	899	774	-	-	996	252	447
Accounts Receivable, after Allowance for Credit Loss, Current	-	8,261	7,672	7,184	6,626	6,484	7,018	6,873	7,071	6,778	7,851	9,230	9,450	10,349	10,278
Inventory, Net	5,868	6,254	6,535	6,226	5,571	4,700	4,866	5,096	5,440	5,978	6,310	5,953	5,911	6,358	6,109
Other current assets	3,651	-	-	-	-	5,153	4,389	4,299	4,500	4,277	5,541	6,987	7,169	8,368	8,706
Total current assets	29,064	33,181	34,857	35,685	33,173	29,764	30,614	24,766	25,875	27,483	27,764	30,266	35,722	32,168	38,782
Investments	2,175	3,458	7,305	9,770	13,515	13,039	11,416	12,125	6,233	1,469	785	370	1,015	252	463
Land	658	623	591	550	541	490	412	365	333	343	350	326	295	326	307
Buildings	11,945	12,733	13,196	13,627	13,101	12,154	11,439	11,726	11,486	11,989	12,645	12,529	13,166	14,966	16,360
Machinery and Equipment, Gross	15,894	16,919	17,188	17,106	16,050	14,261	14,053	14,649	14,441	15,394	16,649	16,303	16,760	17,763	18,283
Construction in progress	2,066	2,198	2,440	1,811	1,448	1,525	1,871	2,301	3,355	5,013	7,324	8,313	9,186	8,262	7,984
Property, plant and equipment (at cost)	30,563	32,473	33,415	33,094	31,140	28,430	27,775	29,041	29,615	32,739	36,968	37,471	39,407	41,317	42,934
Less: accumulated depreciation	13,481	16,176	17,385	18,121	18,004	15,923	15,749	16,602	16,324	17,686	18,982	18,192	17,985	18,266	19,155
Property, plant and equipment, net	17,082	16,297	16,030	14,973	13,136	12,507	12,026	12,439	13,291	15,053	17,986	19,279	21,422	23,051	23,779
Goodwill	12,378	12,155	12,134	12,301	12,992	17,723	18,162	18,284	18,253	19,425	20,238	21,264	21,204	21,197	21,668
Other Intangibles, Net	39,456	34,302	29,083	23,801	20,386	22,602	17,305	14,183	11,431	14,196	14,604	22,933	20,269	18,011	16,370
Other Assets	5,626	-	-	-	-	-	-	-	-	-	-	-	-	11,996	16,044
Total Assets	105,781	105,128	106,132	105,645	98,335	101,779	95,377	87,872	82,637	84,397	91,588	105,694	109,160	106,675	117,106
Debt, Current	2,400	1,990	4,315	4,521	2,704	2,585	568	3,057	5,308	3,610	6,431	2,412	1,946	1,372	2,649
Trade accounts payable	2,308	2,462	1,753	2,274	2,625	2,533	2,807	3,102	3,318	3,738	4,594	4,609	4,264	3,922	4,079
Other Liabilities, Current	-	9,731	9,737	9,501	10,523	11,216	10,274	10,427	10,151	12,549	13,053	13,859	14,159	15,766	15,694
Income taxes payable	1,243	781	1,200	251	1,606	1,560	2,239	708	1,971	736	1,575	1,224	1,986	2,649	3,914
Dividends payable	1,176	1,281	1,343	1,321	1,308	1,309	1,316	1,320	1,458	1,587	1,674	1,768	1,884	1,985	2,084
Total current liabilities	15,641	16,245	18,348	17,868	18,766	19,203	17,204	18,614	22,206	22,220	27,327	23,872	24,239	25,694	28,420
Long-Term Debt	15,482	15,525	16,254	20,539	18,699	23,929	24,274	21,353	19,806	22,736	25,360	30,690	28,745	33,683	34,462
Deferred Income Taxes	-	-	-	-	-	-	-	2,219	1,702	1,470	1,015	3,441	1,795	871	1,387
Other Noncurrent Liabilities	-	-	-	8,136	7,813	7,345	8,514	11,117	12,041	11,970	12,482	9,434	8,323	8,792	6,465
Common Stock, Value, Issued	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788
Other paid-in capital	40,701	40,663	40,646	40,508	40,423	40,222	39,939	39,902	38,808	39,660	39,588	44,238	44,379	44,509	44,704
Retained earnings	37,536	38,990	39,985	39,257	46,021	45,348	44,133	41,350	42,579	46,602	47,362	53,696	61,081	53,895	63,069
Accumulated other comprehensive loss	-3,216	-3,132	-4,682	-2,197	-4,323	-4,148	-5,226	-4,910	-5,545	-6,193	-6,634	-4,429	-4,768	-5,161	-4,945
Stockholders' equity before deduction for treasury stock	-	78,309	77,737	79,356	83,909	83,210	80,634	78,130	77,630	81,857	82,104	95,293	102,480	95,031	104,616
Treasury Stock, Common, Value	-	-	-	-	-	-	-	-	-	-	-	-	56,489	57,450	58,303
Total Merck & Co., Inc. stockholders’ equity	56,805	56,943	55,463	52,326	48,791	44,767	40,308	34,569	26,882	26,001	25,404	38,257	46,058	37,635	46,372
Noncontrolling Interests	2,429	2,426	2,443	2,561	144	91	220	233	181	94	87	73	67	54	59
Total equity	56,805	56,943	55,463	52,326	48,791	44,767	40,308	34,569	26,882	26,001	25,404	38,257	46,058	37,635	46,372
Total Liabilities and Equity	105,781	105,128	106,132	105,645	98,335	101,779	95,377	87,872	82,637	84,397	91,588	105,694	109,160	106,675	117,106